EGFR and malaria: As chloroquine (CQ), together with primaquine, is the first-line treatment recommended for malaria and has been reported to promote anticancer activity and regulate the endocytosis-mediated degradation of EGFR [28,30], we assessed the effects of CQ on breast cancer apoptosis.